Expect to See More Buprenorphine for Chronic Pain

January 1

You’ll see more interest in buprenorphine for chronic pain...as it gains steam in new US guidelines.

These guidelines recommend buprenorphine over full opioid agonists (morphine, etc)...if NON-opioids aren’t enough.

Buprenorphine is a partial agonist at mu-opioid receptors...and an ANTagonist at other opioid receptors.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter Canada includes:

12 issues every year, with brief articles about new meds and hot topics
200+ CE courses, including the popular CE-in-the-Letter
Quick reference drug comparison charts
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get quote

Table of Contents

COVID-19 Share the Latest Guidance About COVID-19 Vaccines
COVID-19 Help Patients Cope With Long COVID
Menopause Clarify Options to Manage Vaginal Menopausal Symptoms
Insulin Answer FAQs About Insulin for Type 2 Diabetes
Antibiotics Put Concerns of Seizure Risk With Cephalosporins in Perspective
Pain Management Expect to See More Buprenorphine for Chronic Pain
Med Safety Stay Alert for Tendon Problems With Aromatase Inhibitors
Cardiology Be Ready for Camzyos for Obstructive Hypertrophic Cardiomyopathy
Medication Errors Help Ensure Ear Meds Aren’t Put in the Eyes